ArticleWorld journal of urology2025
Reinforcing expectations after robot-assisted intracorporeal orthotopic neobladder: long-term functional, urodynamic and metabolic outcome.
Article in World journal of urology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeRobotic-assisted radical cystectomy (RARC) with complete intracorporeal orthotopic neobladder offers a less invasive reconstruction of continent urinary diversion to the open approach. The aim was to evaluate long-term functional, urodynamic, and metabolic outcomes after RARC with intracorporeal orthotopic neobladder.
methodsIn this retrospective study, 18 consecutive patients (16 men, median age 67 years) undergoing RARC for urothelial carcinoma with intracorporeal orthotopic neobladder between November 2015 and May 2021 were included. Video urodynamic evaluations assessed neobladder capacity, pressure at maximum filling, ureteral reflux and post-void residual volume. Continence was evaluated by questionnaires and pad count. Laboratory values were retrieved from the clinic information system. A subgroup of patients underwent both early and a late with video urodynamic studies were performed.
resultsMedian time between RARC with intracorporeal orthotopic neobladder reconstruction and late postoperative studies was 60 months. Urodynamic measurements showed a median maximum neobladder capacity of 485 mL (interquartile range (IQR), 433-625) and a maximum neobladder pressure of 20 cmH
conclusionsThis patient series reports comprehensive long term urodynamic, functional, and metabolic results five years after RARC with intracorporeal orthotopic neobladder reconstruction. In a subgroup analysis, neobladder function, renal function, and metabolic status remained stable between early and late postoperative assessments, which may indicate favorable long-term outcomes.
Indexed as
Identifiers
40668322What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.